Holen Sie sich die Stockscreener-App
0.98
4.85%
-0.05
Vorhandelsmarkt:
1.00
0.02
+2.04%
Schlusskurs vom Vortag:
$1.03
Offen:
$1.02
24-Stunden-Volumen:
192.24K
Relative Volume:
0.67
Marktkapitalisierung:
$15.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.90M
KGV:
-0.00476
EPS:
-206.0125
Netto-Cashflow:
$-12.75M
1W Leistung:
-7.55%
1M Leistung:
-7.55%
6M Leistung:
+5.38%
1J Leistung:
-1.02%
1-Tages-Spanne:
$0.98
$1.06
1-Wochen-Bereich:
$0.98
$1.11
52-Wochen-Spanne:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Firmenname
Allarity Therapeutics Inc
Sektor
Branche
Telefon
401-426-4664
Adresse
24 SCHOOL ST., 2ND FLOOR, BOSTON
Vergleichen Sie ALLR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
0.98 | 16.28M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.31 | 115.75B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.36 | 80.71B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.73 | 52.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
852.04 | 52.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.76 | 37.29B | 447.02M | -1.18B | -906.14M | -6.1812 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Aktie (ALLR) Neueste Nachrichten
How Allarity Therapeutics Inc. stock reacts to Fed rate cutsEarnings Overview Summary & Smart Investment Allocation Tips - Улправда
Is Allarity Therapeutics Inc. stock oversold or undervalued2025 Stock Rankings & Smart Allocation Stock Tips - Улправда
Hedge Fund Bets: How Allarity Therapeutics Inc. stock reacts to Fed rate cuts2025 Major Catalysts & AI Optimized Trading Strategy Guides - Улправда
How strong is Allarity Therapeutics Inc. stock balance sheetJuly 2025 Outlook & Weekly Watchlist for Consistent Profits - Улправда
Will Allarity Therapeutics Inc. stock maintain dividend yieldJuly 2025 Final Week & High Conviction Investment Ideas - DonanımHaber
Published on: 2025-12-19 05:31:28 - ulpravda.ru
Is Allarity Therapeutics Inc. stock a bargain at current levelsJuly 2025 Final Week & Consistent Profit Trade Alerts - Bollywood Helpline
Allarity Therapeutics Earnings Notes - Trefis
Allarity Therapeutics Secures $2.5M Through Private Placement - MSN
Ascendiant Capital Maintains Allarity Therapeutics (ALLR) Buy Recommendation - Nasdaq
ALLR: Ascendiant Capital Raises Price Target, Maintains Buy Rati - GuruFocus
Allarity Therapeutics updates CFO employment agreement with full-time terms By Investing.com - Investing.com Australia
Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO - TipRanks
Allarity Therapeutics updates CFO employment agreement with full-time terms - Investing.com
Will Allarity Therapeutics Inc. stock benefit from sector rotationTrade Exit Summary & Trade Opportunity Analysis - Newser
Will Allarity Therapeutics Inc. stock return to pre crisis levelsPortfolio Update Report & High Yield Stock Recommendations - Newser
Can Allarity Therapeutics Inc. stock continue upward trendJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Allarity Therapeutics Inc to offer up to $50 million in securities - marketscreener.com
How Allarity Therapeutics Inc. stock trades before earningsJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ
Published on: 2025-11-28 11:27:30 - moha.gov.vn
Is Allarity Therapeutics Inc. stock a buy before product launchesJuly 2025 Sector Moves & Fast Gaining Stock Reports - BỘ NỘI VỤ
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Allarity Therapeutics Inc. (ALLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Metastatic Breast Cancer Pipeline Insights Report 2025: Uncovering Breakthrough Drug Candidates Driving Future Market Growth - The Globe and Mail
Allarity Therapeutics, Inc. (ALLR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is it too late to sell Allarity Therapeutics Inc.July 2025 Movers & High Yield Equity Trading Tips - newser.com
How Allarity Therapeutics Inc. stock performs in weak economyShare Buyback & Verified Momentum Stock Watchlist - newser.com
Will Allarity Therapeutics Inc. stock continue upward momentumJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Why Allarity Therapeutics Inc. stock appeals to analystsPortfolio Performance Report & Technical Pattern Based Signals - newser.com
Why retail investors pile into Allarity Therapeutics Inc. stockWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
How Allarity Therapeutics Inc. stock reacts to oil pricesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Applying big data sentiment scoring on Allarity Therapeutics Inc.July 2025 Summary & Fast Momentum Entry Tips - newser.com
Exit strategy if you’re trapped in Allarity Therapeutics Inc.Market Sentiment Summary & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-11-19 00:17:48 - newser.com
Why hedge funds are buying Allarity Therapeutics Inc. stock2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Real time breakdown of Allarity Therapeutics Inc. stock performanceMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Is Allarity Therapeutics Inc. stock affected by interest rate hikesJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
Allarity Therapeutics Inc Stock Analysis and ForecastTake Profit Strategies & Smart Trading Plans for Every Investor Type - earlytimes.in
Using AI based signals to follow Allarity Therapeutics Inc.Earnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Can momentum traders help lift Allarity Therapeutics Inc.Quarterly Trade Review & Short-Term High Return Strategies - newser.com
Published on: 2025-11-15 17:56:44 - newser.com
Finanzdaten der Allarity Therapeutics Inc-Aktie (ALLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
1.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):